Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review
Date:
February 2017
This open-access review summarizes and critiques six previously published estimates of the costs or cost-effectiveness of CCHD screening from the United Kingdom, the United States, and China. Several elements that affect CCHD screening costs were assessed in varying numbers of studies, including screening staff time, instrumentation, and consumables, as well as costs of diagnosis and treatment.
Grosse, S. D., Peterson, C., Abouk, R., Glidewell, J., & Oster, M. E. (2017). Cost and cost-effectiveness assessments of newborn screening for critical congenital heart disease using pulse oximetry: A review. International Journal of Neonatal Screening, 3(4), 34. https://doi.org/10.3390/injs3040034